Covered recipient · General Payments record
MATTIE LYNN AEKINS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$804.84
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $378.82 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $157.53 | 3 |
| Novo Nordisk AS | $142.10 | 2 |
| Amgen Inc. | $34.37 | 2 |
| Astellas Pharma US Inc | $25.07 | 1 |
| Lilly USA, LLC | $19.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $20.62 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117489670 | CMS |
| Amgen Inc. | $13.75 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117489672 | CMS |
| Astellas Pharma US Inc | $25.07 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139560831 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.91 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105382478 | CMS |
| AstraZeneca Pharmaceuticals LP | $34.79 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104318058 | CMS |
| AstraZeneca Pharmaceuticals LP | $106.83 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105642090 | CMS |
| Lilly USA, LLC | $19.75 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135817698 | CMS |
| Novo Nordisk Inc | $17.36 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100299869 | CMS |
| Novo Nordisk Inc | $124.74 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100609224 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.